The analysis of the genes of interest using RNA sequencing data from TCGA suggested the possible use of some of them as biomarkers for glioma class differentiation, with DPYSL2 demonstrated as a glioma-specific biomarker. Here, DPYSL2 is linked to central nervous system cancer.